메뉴 건너뛰기




Volumn 25, Issue 3, 2016, Pages 246-253

FDA’s misplaced priorities: Premarket review under the Family Smoking Prevention and Tobacco Control Act

Author keywords

[No Author keywords available]

Indexed keywords

ADVERSE EFFECTS; DIRECT-TO-CONSUMER ADVERTIZING; FOOD AND DRUG ADMINISTRATION; GOVERNMENT REGULATION; HEALTH CARE POLICY; HUMAN; LEGISLATION AND JURISPRUDENCE; MANAGEMENT; PREVENTION AND CONTROL; PRODUCT SAFETY; PROGRAM EVALUATION; SMOKING; TOBACCO; TOBACCO INDUSTRY; UNITED STATES;

EID: 84964344425     PISSN: 09644563     EISSN: 14683318     Source Type: Journal    
DOI: 10.1136/tobaccocontrol-2015-052391     Document Type: Article
Times cited : (12)

References (49)
  • 1
    • 85052186417 scopus 로고    scopus 로고
    • Family Smoking Prevention and Tobacco Control Act § 910(a)(1), Pub. L. No. 111-31, 123 Stat. 1776 (June 22, 2009)
    • Family Smoking Prevention and Tobacco Control Act § 910(a)(1), Pub. L. No. 111-31, 123 Stat. 1776 (June 22, 2009).
  • 2
    • 85052187446 scopus 로고    scopus 로고
    • Family Smoking Prevention and Tobacco Control Act § 910(a)(2), Pub. L. No. 111-31, 123 Stat. 1776 (June 22, 2009)
    • Family Smoking Prevention and Tobacco Control Act § 910(a)(2), Pub. L. No. 111-31, 123 Stat. 1776 (June 22, 2009).
  • 3
    • 84965339203 scopus 로고    scopus 로고
    • The health consequences of smoking—50 years of progress
    • US Department of Health and Human Services, Atlanta, GA: US Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health, 2014. Family Smoking Prevention and Tobacco Control Act § 910(b), Pub. L. No. 111-31, 123 Stat. 1776 (June 22, 2009)
    • US Department of Health and Human Services. The health consequences of smoking—50 years of progress. A report of the Surgeon General. Atlanta, GA: US Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health, 2014. Family Smoking Prevention and Tobacco Control Act § 910(b), Pub. L. No. 111-31, 123 Stat. 1776 (June 22, 2009).
    • A Report of the Surgeon General
  • 4
    • 84928205170 scopus 로고    scopus 로고
    • Smokeless tobacco products sold in Massachusetts from 2003 to 2012: Trends and variations in brand availability, nicotine contents and design features
    • Cullen D, Keithly L, Kane K, et al. Smokeless tobacco products sold in Massachusetts from 2003 to 2012: trends and variations in brand availability, nicotine contents and design features. Tob Control 2015;24:256–62.
    • (2015) Tob Control , vol.24 , pp. 256-262
    • Cullen, D.1    Keithly, L.2    Kane, K.3
  • 5
    • 38449090570 scopus 로고    scopus 로고
    • Trends in nicotine yield in smoke and its relationship with design characteristics among popular US cigarette brands, 1997–2005
    • Connolly GN, Alpert HR, Wayne GF, et al. Trends in nicotine yield in smoke and its relationship with design characteristics among popular US cigarette brands, 1997–2005. Tob Control 2007;16:e5.
    • (2007) Tob Control , vol.e5 , pp. 16
    • Connolly, G.N.1    Alpert, H.R.2    Wayne, G.F.3
  • 6
    • 0003012924 scopus 로고    scopus 로고
    • How cigarette design can affect youth initiation into smoking: Camel cigarettes 1983–93
    • Wayne G, Connolly G. How cigarette design can affect youth initiation into smoking: camel cigarettes 1983–93. Tob Control 2002;11 (Suppl I):i32-9.
    • (2002) Tob Control , vol.11 , pp. i32-i39
    • Wayne, G.1    Connolly, G.2
  • 7
    • 84991898251 scopus 로고    scopus 로고
    • United States. v. Philip Morris USA, Inc., 449 F.Supp.2d 1 (D.D.C. 2006)
    • United States. v. Philip Morris USA, Inc., 449 F.Supp.2d 1 (D.D.C. 2006).
  • 8
    • 84991852549 scopus 로고    scopus 로고
    • H.R. REP. NO. 111-58, pt. 1, at 4 (2009), reprinted in 2009 U.S.C.C.A.N. 468, 470
    • H.R. REP. NO. 111-58, pt. 1, at 4 (2009), reprinted in 2009 U.S.C.C.A.N. 468, 470.
  • 9
    • 85052187358 scopus 로고    scopus 로고
    • Family Smoking Prevention and Tobacco Control Act § 910(c)(4), Pub. L. No. 111-31, 123 Stat. 1776 (June 22, 2009)
    • Family Smoking Prevention and Tobacco Control Act § 910(c)(4), Pub. L. No. 111-31, 123 Stat. 1776 (June 22, 2009).
  • 10
    • 85052187749 scopus 로고    scopus 로고
    • Family Smoking Prevention and Tobacco Control Act § 910(a)(3), Pub. L. No. 111-31, 123 Stat. 1776 (June 22, 2009)
    • Family Smoking Prevention and Tobacco Control Act § 910(a)(3), Pub. L. No. 111-31, 123 Stat. 1776 (June 22, 2009).
  • 11
    • 84991893214 scopus 로고    scopus 로고
    • U.S. Food and Drug Administration, Silver Spring, MD: U.S. Food and Drug Administration, [updated 1/30/2014; cited 24 July 2015]
    • U.S. Food and Drug Administration. Substantial equivalence. Silver Spring, MD: U.S. Food and Drug Administration, 2014 [updated 1/30/2014; cited 24 July 2015]. http://www.fda.gov/TobaccoProducts/Labeling/TobaccoProductReviewEvaluation/NewTobaccoProductReviewandEvaluation/SubstantialEquivalence/default.htm
    • (2014) Substantial Equivalence
  • 12
    • 84991915805 scopus 로고    scopus 로고
    • U. S. Government Accountability Office, U.S. Senate, New Tobacco Products, FDA Needs to Set Time Frames for Its Review Process. Washington DC: U.S. Government Accountability Office, 2013 (cited 2015 July 24)
    • U. S. Government Accountability Office. Report to the Ranking Member, Subcommittee on Primary Health and Aging, Committee on health, Education, Labor, and Pensions, U.S. Senate, New Tobacco Products, FDA Needs to Set Time Frames for Its Review Process. Washington DC: U.S. Government Accountability Office, 2013 (cited 2015 July 24). http://www.gao.gov/assets/660/657451.pdf
    • Report to the Ranking Member, Subcommittee on Primary Health and Aging, Committee on Health, Education, Labor, and Pensions
  • 13
    • 84877288593 scopus 로고    scopus 로고
    • Understanding the Tobacco Control Act: Efforts by the US Food and Drug Administration to make tobacco-related morbidity and mortality part of the USA’s past, not its future
    • Husten C, Deyton L. Understanding the Tobacco Control Act: efforts by the US Food and Drug Administration to make tobacco-related morbidity and mortality part of the USA’s past, not its future. Lancet 2013;381:1570–80.
    • (2013) Lancet , vol.381 , pp. 1570-1580
    • Husten, C.1    Deyton, L.2
  • 14
    • 84991859754 scopus 로고    scopus 로고
    • U.S. Food and Drug Administration, Silver Spring, MD: U.S. Food and Drug Administration, 2012 (cited 24 July 2015)
    • U.S. Food and Drug Administration. Reports on Substantial Equivalence (905(j)(1) (A)(i) Reports): One Year Later. Silver Spring, MD: U.S. Food and Drug Administration, 2012 (cited 24 July 2015). http://www.fda.gov/downloads/TobaccoProducts/ResourcesforYou/ForIndustry/Retailer/UCM301597.pdf
    • Reports on Substantial Equivalence (905(J)(1) (A)(I) Reports): One Year Later
  • 15
    • 84991859754 scopus 로고    scopus 로고
    • U.S. Food and Drug Administration, Silver Spring, MD: U.S. Food and Drug Administration, 2012 (cited 24 July 2015)
    • U.S. Food and Drug Administration. Reports on Substantial Equivalence (905(j)(1) (A)(i) Reports): An Update. Silver Spring, MD: U.S. Food and Drug Administration, 2012 (cited 24 July 2015). http://www.fda.gov/downloads/TobaccoProducts/ResourcesforYou/BreakTheChain/UCM316450.pdf
    • Reports on Substantial Equivalence (905(J)(1) (A)(I) Reports): An Update
  • 16
    • 84991897823 scopus 로고    scopus 로고
    • U.S. Food and Drug Administration, Silver Spring, MD: U.S. Food and Drug Administration, 2013 (cited 24 July 2015)
    • U.S. Food and Drug Administration. Update on Review of Substantial Equivalence Reports (SE Reports). Silver Spring, MD: U.S. Food and Drug Administration, 2013 (cited 24 July 2015). http://www.fda.gov/downloads/TobaccoProducts/ResourcesforYou/BreakTheChain/UCM347933.pdf
    • Update on Review of Substantial Equivalence Reports (SE Reports)
  • 17
    • 84991889943 scopus 로고    scopus 로고
    • U.S. Food and Drug Administration, Silver Spring, MD: U.S. Food and Drug Administration, 2013 (cited 24 July 2015)
    • U.S. Food and Drug Administration. Cumulative number of Substantial Equivalence (SE) Provisional reports received (1). Silver Spring, MD: U.S. Food and Drug Administration, 2013 (cited 24 July 2015). http://www.accessdata.fda.gov/FDATrack/track?program=ctp&id=CTP-OS-provisional-SE-reports&fy=all
    • Cumulative Number of Substantial Equivalence (SE) Provisional Reports Received (1)
  • 18
    • 84901460390 scopus 로고    scopus 로고
    • Adverse publicity by administrative agencies in the internet era
    • Cortez N. Adverse publicity by administrative agencies in the internet era. Brigham Young Univ Law Review 2011;2011:1371–454.
    • (2011) Brigham Young Univ Law Review , vol.2011 , pp. 1371-1454
    • Cortez, N.1
  • 19
    • 84991911829 scopus 로고    scopus 로고
    • U.S. Food and Drug Administration, Silver Spring, MD: U.S. Food and Drug Administration, 2013 (updated 12/31/2013; cited 24 July 2015)
    • U.S. Food and Drug Administration. Total number of product submissions received or filed in the month (1). Silver Spring, MD: U.S. Food and Drug Administration, 2013 (updated 12/31/2013; cited 24 July 2015). http://www.accessdata.fda.gov/FDATrack/track?program=ctp&id=CTP-OS-total-product-submissions-received&fy=all
    • Total Number of Product Submissions Received Or Filed in the Month (1)
  • 20
    • 84991878735 scopus 로고    scopus 로고
    • U.S. Food and Drug Administration, Silver Spring, MD: U.S. Food and Drug Administration, (updated 8/7/2012; cited 24 July 2015)
    • U.S. Food and Drug Administration. New tobacco product review and evaluation. Silver Spring, MD: U.S. Food and Drug Administration, 2012 (updated 8/7/2012; cited 24 July 2015). http://www.fda.gov/TobaccoProducts/Labeling/TobaccoProductReviewEvaluation/NewTobaccoProductReviewandEvaluation/default.htm
    • (2012) New Tobacco Product Review and Evaluation
  • 21
    • 84991838385 scopus 로고    scopus 로고
    • U.S. Department of Health and Human Services, U.S. Food and Drug Administration, Silver Spring, MD: U.S. Food and Drug Administration, 2013 (cited 24 July 2015)
    • U.S. Department of Health and Human Services, U.S. Food and Drug Administration. Report to Congress, Progress and Effectiveness of the Implementation of the Family Smoking Prevention and Tobacco Control Act. Silver Spring, MD: U.S. Food and Drug Administration, 2013 (cited 24 July 2015). http://www.fda.gov/downloads/TobaccoProducts/GuidanceComplianceRegulatoryInformation/UCM371271.pdf
    • Report to Congress, Progress and Effectiveness of the Implementation of the Family Smoking Prevention and Tobacco Control Act
  • 22
    • 84991896288 scopus 로고    scopus 로고
    • U.S. Food and Drug Administration, Silver Spring, MD: U.S. Food and Drug Administration, 2014 (cited 24 July 2015)
    • U.S. Food and Drug Administration. Substantial Equivalence: The Review Profess for Regular Reports. Silver Spring, MD: U.S. Food and Drug Administration, 2014 (cited 24 July 2015). http://www.fda.gov/TobaccoProducts/Labeling/TobaccoProductReviewEvaluation/NewTobaccoProductReviewandEvaluation/SubstantialEquivalence/ucm419890.htm
    • Substantial Equivalence: The Review Profess for Regular Reports
  • 23
    • 84991889943 scopus 로고    scopus 로고
    • U.S. Food and Drug Administration, Silver Spring, MD: U.S. Food and Drug Administration, 2013 [updated 12/31/2013; cited 24 July 2015]
    • U.S. Food and Drug Administration. Cumulative number of Substantial Equivalence (SE) reports received (1). Silver Spring, MD: U.S. Food and Drug Administration, 2013 [updated 12/31/2013; cited 24 July 2015]. http://www.accessdata.fda.gov/FDATrack/track?program=ctp&id=CTP-OS-regular-SE-reports&fy=all
    • Cumulative Number of Substantial Equivalence (SE) Reports Received (1)
  • 24
    • 84991858587 scopus 로고    scopus 로고
    • Memo to Richard J. Turman (Deputy Director, Center for Tobacco Products, U.S. Food and Drug Administration, Silver Spring, MD) 18 April 2014 (cited 24 July 2015)
    • Ashley DL. (Director, Office of Science, Center for Tobacco Products, U.S. Food and Drug Administration, Silver Spring, MD). Memo to Richard J. Turman (Deputy Director, Center for Tobacco Products, U.S. Food and Drug Administration, Silver Spring, MD) 18 April 2014 (cited 24 July 2015). http://www.fda.gov/downloads/TobaccoProducts/NewsEvents/UCM393907.pdf
    • Director, Office of Science, Center for Tobacco Products, U.S. Food and Drug Administration, Silver Spring, MD
    • Ashley, D.L.1
  • 25
    • 84991876378 scopus 로고    scopus 로고
    • CSPnet.com. 27 April 2015 (cited 24 July 2015)
    • Vonder Haar M. Five Fresh Insights into Tobacco Regulation. CSPnet.com. 27 April 2015 (cited 24 July 2015). http://www.cspnet.com/category-news/tobacco/articles/five-fresh-insights-tobacco-regulation
    • Five Fresh Insights into Tobacco Regulation
    • Vonder Haar, M.1
  • 26
    • 84991899210 scopus 로고    scopus 로고
    • U.S. Food and Drug Administration. Technical Project Lead (TPL) Review: SE0002424-SE0002460, SE0002462, SE0002464-SE0002474, SE0002479-SE0002482, SE0002484, SE0002495-SE0002511, SE0002513-SE0002518, SE0002520-SE0002534, and SE0002541-SE0002543. Silver Spring, MD: U.S. Food and Drug Administration, 2015 (cited 7 December 2015)
    • U.S. Food and Drug Administration. Technical Project Lead (TPL) Review: SE0002424-SE0002460, SE0002462, SE0002464-SE0002474, SE0002479-SE0002482, SE0002484, SE0002495-SE0002511, SE0002513-SE0002518, SE0002520-SE0002534, and SE0002541-SE0002543. Silver Spring, MD: U.S. Food and Drug Administration, 2015 (cited 7 December 2015). http://www.fda.gov/downloads/TobaccoProducts/Labeling/MarketingandAdvertising/UCM465259.pdf
  • 27
    • 84991891531 scopus 로고    scopus 로고
    • U.S. Food and Drug Administration, Silver Spring, MD: U.S. Food and Drug Administration, 2014 (cited 24 July 2015)
    • U.S. Food and Drug Administration. Technical Project Lead (TPL) Memorandum: SE Reports SE0003441, SE0003442, SE0003443, SE0003444. Silver Spring, MD: U.S. Food and Drug Administration, 2014 (cited 24 July 2015). http://www.fda.gov/downloads/TobaccoProducts/Labeling/MarketingandAdvertising/UCM386756.pdf
    • Technical Project Lead (TPL) Memorandum: SE Reports SE0003441, SE0003442, SE0003443, SE0003444
  • 28
    • 84991878032 scopus 로고    scopus 로고
    • Guidance for Industry and Food and Drug Administration Staff. Section 905(j) Reports: Demonstrating Substantial Equivalence for Tobacco Products and Demonstrating the Substantial Equivalence of a New Tobacco Product: Responses to Frequently Asked Questions
    • Office of the Federal Register, Food and Drug Administration, Agency Information Collection Activities; Proposed Collection; Comment Request, Washington DC: Food and Drug Administration, 2015 (cited 24 July 2015)
    • Office of the Federal Register, Food and Drug Administration, Agency Information Collection Activities; Proposed Collection; Comment Request; Guidance for Industry and Food and Drug Administration Staff. Section 905(j) Reports: Demonstrating Substantial Equivalence for Tobacco Products and Demonstrating the Substantial Equivalence of a New Tobacco Product: Responses to Frequently Asked Questions, Federal Register Vol. 80, No. 43. Washington DC: Food and Drug Administration, 2015 (cited 24 July 2015). http://www.gpo.gov/fdsys/pkg/FR-2015-03-05/pdf/2015-05024.pdf
    • Federal Register , vol.80 , Issue.43
  • 29
    • 84991898437 scopus 로고    scopus 로고
    • U.S. Food and Drug Administration, Silver Spring, MD: U.S. Food and Drug Administration, 2012 (cited 24 July 2015)
    • U.S. Food and Drug Administration. Common Issues Identified During FDA’s Scientific Evaluation of SE Reports Summary Brief. Silver Spring, MD: U.S. Food and Drug Administration, 2012 (cited 24 July 2015). http://www.fda.gov/downloads/TobaccoProducts/ResourcesforYou/UCM316553.pdf
    • Common Issues Identified during FDA’s Scientific Evaluation of SE Reports Summary Brief
  • 30
    • 84991876317 scopus 로고    scopus 로고
    • U.S. Food and Drug Administration, Silver Spring, MD: U.S. Food and Drug Administration, 2015 (cited 24 July 2015)
    • U.S. Food and Drug Administration. Technical Project Lead (TPL) Review: SE0001079 and SE0003613—SE0003621. Silver Spring, MD: U.S. Food and Drug Administration, 2015 (cited 24 July 2015). http://www.fda.gov/downloads/TobaccoProducts/Labeling/MarketingandAdvertising/UCM449464.pdf
    • Technical Project Lead (TPL) Review: SE0001079 and SE0003613—SE0003621
  • 31
    • 84991835853 scopus 로고    scopus 로고
    • U.S. Food and Drug Administration, Silver Spring, MD: U.S. Food and Drug Administration, 2015 (cited 1 October 2015)
    • U.S. Food and Drug Administration. Technical Project Lead (TPL) Review: SE0000515. Silver Spring, MD: U.S. Food and Drug Administration, 2015 (cited 1 October 2015). http://www.fda.gov/downloads/TobaccoProducts/Labeling/MarketingandAdvertising/UCM460006.pdf
    • Technical Project Lead (TPL) Review: SE0000515
  • 32
    • 84991913187 scopus 로고    scopus 로고
    • U.S. Food and Drug Administration, Silver Spring, MD: U.S. Food and Drug Administration, 2015 (cited 1 October 2015)
    • U.S. Food and Drug Administration. Technical Project Lead (TPL) Review: SE0002648. Silver Spring, MD: U.S. Food and Drug Administration, 2015 (cited 1 October 2015). http://www.fda.gov/downloads/TobaccoProducts/Labeling/MarketingandAdvertising/UCM461525.pdf
    • Technical Project Lead (TPL) Review: SE0002648
  • 33
    • 84991906173 scopus 로고    scopus 로고
    • U.S. Food and Drug Administration, Silver Spring, MD: U.S. Food and Drug Administration, 2015 (cited 1 October 2015)
    • U.S. Food and Drug Administration. Technical Project Lead (TPL) Review: SE0000276, SE0000277, SE0000278, SE0000281. Silver Spring, MD: U.S. Food and Drug Administration, 2015 (cited 1 October 2015). http://www.fda.gov/downloads/TobaccoProducts/Labeling/MarketingandAdvertising/UCM462402.pdf
    • Technical Project Lead (TPL) Review: SE0000276, SE0000277, SE0000278, SE0000281
  • 34
    • 84991898238 scopus 로고    scopus 로고
    • A Look at Tobacco in 2012
    • Vonder Haar M. A Look at Tobacco in 2012. CSP, 2012:159-66. http://www.cspnet.com/sites/default/files/magazine-files/1210_F5_tobacco%20surprises.pdf
    • (2012) CSP , pp. 159-166
    • Vonder Haar, M.1
  • 35
    • 84991914151 scopus 로고    scopus 로고
    • CSP Daily News, CSPnet.com. 23 February 2012 (cited 2015 December 7)
    • CSP Daily News. Consumers Switching Between Tobacco Types. CSPnet.com. 23 February 2012 (cited 2015 December 7). http://www.cspnet.com/industry-newsanalysis/marketing-strategies/articles/consumers-switching-between-tobacco-types
    • Consumers Switching between Tobacco Types
  • 36
    • 84991859356 scopus 로고    scopus 로고
    • Altria Group, Inc, Washington DC: United States Securities and Exchange Commission, 2012 (cited 24 July 2015)
    • Altria Group, Inc. Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the quarterly period ended 30 September 2012. Washington DC: United States Securities and Exchange Commission, 2012 (cited 24 July 2015). http://services.corporate-ir.net/SEC/Document.Service?id=P3VybD1hSFIwY0RvdkwyRndhUzUwWlc1cmQybDZZWEprTG1OdmJTOWtiM2R1Ykc5aFpDNXdhSEEvWVdOMGFXOXVQVkJFUmlacGNHRm5aVDA0TlRNd09UazBKbk4xWW5OcFpEMDFOdz09JnR5cGU9MiZmbj1BbHRyaWFHcm91cEluYy5wZGY=
    • Quarterly Report Pursuant to Section 13 Or 15(D) of the Securities Exchange Act of 1934 for the Quarterly Period Ended 30 September 2012
  • 37
    • 84991862646 scopus 로고    scopus 로고
    • Altria Group, Inc, Washington DC: United States Securities and Exchange Commission, (cited 24 July 2015)
    • Altria Group, Inc. Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the quarterly period ended 30 June 2013. Washington DC: United States Securities and Exchange Commission, 2013 (cited 24 July 2015). http://services.corporate-ir.net/SEC/Document.Service?id=P3VybD1hSFIwY0RvdkwyRndhUzUwWlc1cmQybDZZWEprTG1OdmJTOWtiM2R1Ykc5aFpDNXdhSEEvWVdOMGFXOXVQVkJFUmlacGNHRm5aVDA1TURNNU9EUXdKbk4xWW5OcFpEMDFOdz09JnR5cGU9MiZmbj1BbHRyaWFHcm91cEluYy5wZGY=
    • (2013) Quarterly Report Pursuant to Section 13 Or 15(D) of the Securities Exchange Act of 1934 for the Quarterly Period Ended 30 June 2013
  • 38
    • 84991879797 scopus 로고    scopus 로고
    • The cigarette crystal ball
    • Vonder Haar M. The cigarette crystal ball. CSP, 2014:75–8. http://www.cspnet.com/sites/default/files/magazine-files/1401_F2-Tobacco.pdf
    • (2014) CSP , pp. 75-78
    • Vonder Haar, M.1
  • 40
    • 84991856908 scopus 로고    scopus 로고
    • Convenience Store News. 2016 Feb. 1 [cited 2016 April 4]
    • Kress M. Altria’s Operating Companies Report a Productive 2015. Convenience Store News. 2016 Feb. 1 [cited 2016 April 4]. Available from http://www.csnews.com/product-categories/tobacco/altrias-operating-companies-report-productive-2015.
    • Altria’s Operating Companies Report a Productive 2015
    • Kress, M.1
  • 41
    • 84991862981 scopus 로고    scopus 로고
    • Reynolds’s New Cigarette Merely Heats Tobacco
    • 17 November, (cited 24 July 2015)
    • Mickle T. Reynolds’s New Cigarette Merely Heats Tobacco. Wall Street Journal 17 November 2014 (cited 24 July 2015). http://www.wsj.com/articles/reynolds-american-plans-new-cigarette-which-wont-burn-tobacco-1416256130
    • (2014) Wall Street Journal
    • Mickle, T.1
  • 42
    • 84991848006 scopus 로고    scopus 로고
    • Reynolds expands distribution for its top-selling cigarette and new snuff brand
    • 31 March, (cited 24 July 2015)
    • Craver R. Reynolds expands distribution for its top-selling cigarette and new snuff brand. Winston-Salem Journal 31 March 2015 (cited 24 July 2015). http://www.journalnow.com/business/business_news/local/reynolds-expands-distribution-for-itstop-selling-cigarette-and-new/article_803c5a48-d7d8-11e4-8a02-c7067fd3b64c.html
    • (2015) Winston-Salem Journal
    • Craver, R.1
  • 43
    • 84939510616 scopus 로고    scopus 로고
    • Reynolds American, Winston-Salem, NC: Reynolds American Inc, cited 24 July 2015
    • Reynolds American. Transformation—past, present, future. Winston-Salem, NC: Reynolds American Inc, 2014 (cited 24 July 2015). http://files.shareholder.com/downloads/RAI/451712306×0x794523/530E0B5A-09C1-4DEF-83A7-5F6182F79065/RAI_2014_Investor_Day_PDF.pdf
    • (2014) Transformation—past, Present, Future
  • 44
    • 84991907446 scopus 로고    scopus 로고
    • Reynolds’ decision to stop marketing of heated cigarette Revo illustrates challenges in selling adult smokers on new products
    • 2 August, (cited 7 December 2015)
    • Craver R. Reynolds’ decision to stop marketing of heated cigarette Revo illustrates challenges in selling adult smokers on new products. Winston-Salem Journal 2 August 2015 (cited 7 December 2015). http://www.journalnow.com/business/business_news/local/reynolds-decision-to-stop-marketing-of-heated-cigaretterevo-illustrates/article_afc1a516-29dc-55a5-8a54-75bd32cddd60.html
    • (2015) Winston-Salem Journal
    • Craver, R.1
  • 45
    • 84991870690 scopus 로고    scopus 로고
    • Nancy Sturgeon (RAI Services Company, Winston-Salem, NC), (Assistant Attorney General, Office of the Attorney General of Vermont, Montpelier, VT) 2015 Sept. 16 (cited 7 December 2015)
    • Nancy Sturgeon (RAI Services Company, Winston-Salem, NC). Letter to Helen Wagner (Assistant Attorney General, Office of the Attorney General of Vermont, Montpelier, VT) 2015 Sept. 16 (cited 7 December 2015). http://vtrga.org/uploads/1443539948.pdf
    • Letter to Helen Wagner
  • 46
    • 84904345638 scopus 로고    scopus 로고
    • Monitoring tobacco-specific N-nitrosamines and nicotine in novel smokeless tobacco products: Findings from round II of the new product watch
    • Stepanov I, Biener L, Yershova K, et al. Monitoring tobacco-specific N-nitrosamines and nicotine in novel smokeless tobacco products: findings from round II of the new product watch. Nicotine Tob Res 2014;16:1070–8.
    • (2014) Nicotine Tob Res , vol.16 , pp. 1070-1078
    • Stepanov, I.1    Biener, L.2    Yershova, K.3
  • 47
    • 84867129791 scopus 로고    scopus 로고
    • Increased pouch sizes and resulting changes in the amounts of nicotine and tobacco-specific N-nitrosamines in single poucehs of camel snus and marlboro snus
    • Stepanov I, Jensen J, Biener L, et al. Increased pouch sizes and resulting changes in the amounts of nicotine and tobacco-specific N-nitrosamines in single poucehs of camel snus and marlboro snus. Nicotine Tob Res 2012;14:1241–5.
    • (2012) Nicotine Tob Res , vol.14 , pp. 1241-1245
    • Stepanov, I.1    Jensen, J.2    Biener, L.3
  • 48
    • 85052187479 scopus 로고    scopus 로고
    • Family Smoking Prevention and Tobacco Control Act § 920(b), Pub. L. No. 111-31, 123 Stat. 1776 (June 22, 2009)
    • Family Smoking Prevention and Tobacco Control Act § 920(b), Pub. L. No. 111-31, 123 Stat. 1776 (June 22, 2009).
  • 49
    • 84991843601 scopus 로고    scopus 로고
    • (Commissioner, New York City Department of Health & Mental Hygiene, New York, NY), (Division of Dockets Management, Rockville, MD) 2013 March 6 (cited 7 December 2015)
    • Thomas Farley (Commissioner, New York City Department of Health & Mental Hygiene, New York, NY). Petition to U.S. Food and Drug Administration (Division of Dockets Management, Rockville, MD) 2013 March 6 (cited 7 December 2015). http://www.regulations.gov/#!docketDetail;D=FDA-2013-P-0285
    • Petition to U.S. Food and Drug Administration
    • Farley, T.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.